Obturator Block in Lateral Tumors of the Bladder: Does it Have Adverse Effects on Early Postoperative Mobilization?

Sponsor
Ankara City Hospital Bilkent (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05652309
Collaborator
(none)
70
1
11
6.4

Study Details

Study Description

Brief Summary

Investigation of delay in postoperative mobilization due to motor block and complications related to block in patients who underwent USG-assisted obturator nerve block with distal approach

Condition or Disease Intervention/Treatment Phase
  • Procedure: spinal block and obturator nerve block

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
70 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Obturator Block in Lateral Tumors of the Bladder: Does it Have Adverse Effects on Early Postoperative Mobilization?
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
spinal anesthesia

spinal block will be performed to patients after monitoring

Procedure: spinal block and obturator nerve block
spinal block and obturator nerve block

spinal anesthesia and obturator nerve block

spinal block will be performed to patients after monitoring, and then the patients in the ONB block group will be given the appropriate position, with a USG-assisted distal approach, 5 cc %2 prilocain into the anterior and 5cc %2 prilocain into the posterior branch of the obturator nerve.

Procedure: spinal block and obturator nerve block
spinal block and obturator nerve block

Outcome Measures

Primary Outcome Measures

  1. pin prick test [postoperatively 2nd hour]

    postoperatively sensation block

  2. bromage score [postoperatively 2nd hour]

    motorial block

  3. pin prick test [postoperatively 5th hour]

    postoperatively sensation block

  4. bromage score [postoperatively 5th hour]

    motorial block

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age between 18-75

  • ASA1, ASA2, ASA 3 physical status

Exclusion Criteria:
  1. The patient's refusal

  2. Active infection in the area to be blocked

  3. Kidney failure

  4. Liver failure

  5. Heart failure

  6. BMI less than 18 and a BMI greater than 40

Contacts and Locations

Locations

Site City State Country Postal Code
1 Serap Diker Ankara Çankaya Turkey

Sponsors and Collaborators

  • Ankara City Hospital Bilkent

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Serap Diker, Anesthesiology and Reanimation, Ankara City Hospital Bilkent
ClinicalTrials.gov Identifier:
NCT05652309
Other Study ID Numbers:
  • E2-22-1854
First Posted:
Dec 15, 2022
Last Update Posted:
Dec 15, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 15, 2022